DY3002
Code | Size | Price |
---|
TAR-T27225-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T27225-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T27225-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
DY3002 is a novel, selective and potent EGFR Inhibitor, it overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer.
CAS:
2020015-37-4
Formula:
C24H25ClN6O2
Molecular Weight:
464.95
Purity:
0.98
SMILES:
Clc1cnc(Nc2ccc(CN3CCOCC3)cc2)nc1Nc1cccc(NC(=O)C=C)c1
References
1. Li Y, Song Z, Jin Y, Tang Z, Kang J, Ma X. Novel Selective and Potent EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer. Molecules. 2016 Nov 2;21(11). pii: E1462. PubMed PMID: 27827863.